Reveal Technology Secures $30 Million in Series B Funding
July 29, 2025 - 14:57
Reveal Technology, a defense technology company founded by veterans, has successfully completed a $30 million Series B funding round. This significant investment was led by Ballistic Ventures, a firm known for its focus on innovative defense solutions.
The funds raised will be instrumental in advancing the company's mission to enhance national security through cutting-edge technology. Reveal Technology specializes in developing solutions that leverage artificial intelligence and machine learning to improve defense capabilities. The new capital will be used to accelerate product development and expand the company's market reach.
The leadership at Reveal expressed gratitude for the support from their investors and highlighted the importance of this funding in driving their vision forward. With the defense sector increasingly relying on advanced technology to address evolving threats, Reveal Technology is poised to make a substantial impact in the industry. The company aims to continue its growth trajectory and deliver innovative solutions that meet the needs of modern defense operations.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...